Literature DB >> 16818681

Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer.

Frederic J Kaye1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16818681     DOI： 10.1158/1078-0432.CCR-06-0791

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  9 in total

1.  Central mucoepidermoid carcinoma, a case report with molecular analysis of the TORC1/MAML2 gene fusion.

Authors:  Haseeb Ahmed Khan; Asif Loya; Rafay Azhar; Nasir Ud Din; Diana Bell
Journal:  Head Neck Pathol       Date:  2010-07-13

Review 2.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

3.  CRTC1 expression during normal and abnormal salivary gland development supports a precursor cell origin for mucoepidermoid cancer.

Authors:  Tina Jaskoll; Khine Htet; George Abichaker; Frederic J Kaye; Michael Melnick
Journal:  Gene Expr Patterns       Date:  2010-09-15       Impact factor: 1.224

4.  Immunohistochemical expression of the oncogenic molecules active Stat3 and survivin in benign and malignant salivary gland tumors.

Authors:  Nikolaos G Nikitakis; Mark A Scheper; Vasileios S Papanikolaou; Alexandra Sklavounou; John J Sauk
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-03-09

5.  Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma.

Authors:  Kristy A Warner; April Adams; Lisiane Bernardi; Carolina Nor; Kelsey A Finkel; Zhaocheng Zhang; Scott A McLean; Joseph Helman; Gregory T Wolf; Vasu Divi; Lurdes Queimado; Frederic J Kaye; Rogerio M Castilho; Jacques E Nör
Journal:  Oral Oncol       Date:  2013-09-12       Impact factor: 5.337

6.  CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.

Authors:  Antonio L Amelio; Mohammad Fallahi; Franz X Schaub; Min Zhang; Mariam B Lawani; Adam S Alperstein; Mark R Southern; Brandon M Young; Lizi Wu; Maria Zajac-Kaye; Frederic J Kaye; John L Cleveland; Michael D Conkright
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

7.  The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.

Authors:  Zirong Chen; Wei Ni; Jian-Liang Li; Shuibin Lin; Xin Zhou; Yuping Sun; Jennifer W Li; Marino E Leon; Maria D Hurtado; Sergei Zolotukhin; Chen Liu; Jianrong Lu; James D Griffin; Frederic J Kaye; Lizi Wu
Journal:  JCI Insight       Date:  2021-04-08

8.  Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.

Authors:  Jie Chen; Jian-Liang Li; Zirong Chen; James D Griffin; Lizi Wu
Journal:  BMC Cancer       Date:  2015-10-26       Impact factor: 4.430

9.  Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer.

Authors:  T Komiya; A Coxon; Y Park; W-D Chen; M Zajac-Kaye; P Meltzer; T Karpova; F J Kaye
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.